Merck (MRK) financial statements

+168.7%since 2007
FY2025 revenue
$65.0B▲ +1.3%
FY2025 net income
$18.3B▲ +6.6%
FY2025 diluted EPS
$7.28▲ +8.0%
FY2025 free cash flow
$12.4B▼ −31.7%

Merck income statement

Merck income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue65,01164,16860,115
Pretax income21,06719,9361,889
Net income18,25417,117365
Diluted earnings per share7.286.740.14

Merck balance sheet

Merck balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents14,56513,2426,841
Total assets136,866117,106106,675
Total liabilities (derived)84,20470,73469,040
Total equity52,66246,37237,635
Long-term debt46,75034,46233,683

Merck cash flow statement

Merck cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow16,47221,46813,006
Capital expenditure-4,112-3,372-3,863
Free cash flow (derived)12,36018,0969,143
Dividends paid-8,176-7,840-7,445
Share repurchases-5,084-1,306-1,346

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)18,08516,60716,28616,400
Net income (derived)5,065-1,335-4,2402,963
Diluted earnings per share2.04-0.54-1.72n/a
Operating cash flow (derived)6,5585,3703,9182,857
Total assets132,773129,802128,685136,866

Merck major shareholders

Merck major shareholders
HolderShare of classSharesFiled
Vanguard Capital Management7.5%186,323,76630 April 2026

Merck 10-K and SEC filings

Merck 10-K and SEC filings
FiledFormTypeDescription
4 November 202610-QQuarterly reportQuarterly report
29 October 20268-KCurrent reportFORM 8-K
13 October 20268-KCurrent reportCurrent report
7 August 202610-QQuarterly reportQuarterly report
4 August 20268-KCurrent reportFORM 8-K
28 May 20268-KCurrent reportFORM 8-K
22 May 20268-KCurrent reportCurrent report
4 May 202610-QQuarterly report1Q26 FORM 10-Q

Common questions

What was Merck's revenue in fiscal 2025?

Merck reported $65.0 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 1.3% from fiscal 2024.

What was Merck's net income in fiscal 2025?

Merck reported net income of $18.3 billion for fiscal 2025, the year ended 31 December 2025, up 6.6% from fiscal 2024. Diluted earnings per share were $7.28.

What was Merck's free cash flow in fiscal 2025?

Merck had $12.4 billion in free cash flow in fiscal 2025. Operating cash flow was $16.5 billion and capital expenditure was $4.1 billion.

What were Merck's total assets at the end of fiscal 2025?

Merck reported total assets of $136.9 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Merck history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.